News from the FDA/CDC
The agency announced newly approved warnings and a new limitation on the approved indication for ulcerative colitis.
Hadlima gets seven of Humira’s indications.
MADRID – Secukinumab was superior to placebo for the primary endpoint of ASAS20 based on the initial 12-week data...
MADRID – Already approved as a treatment for chronic plaque psoriasis, tildrakizumab (Ilumya) may also be beneficial in psoriatic arthritis,...
MILAN – After 1 year of treatment, about half of patients said their psoriasis had no impact on quality of life.
MADRID – The percentage with unacceptable pain despite inflammation control was twice as high for nonresponders versus responders to anti-TNF...
EULAR’s revised psoriatic arthritis recommendations retain methotrexate and other csDMARDS as first-line treatment over TNF inhibitors.
In women, these associations included salmonella infection, sepsis, and uveitis; in men, they included gangrene, encephalitis, and hidradenitis...
Systemic psoriasis treatments less often prescribed in elderly with psoriasis, despite comparable response rates
MILAN – There was an “imbalance” in the types of medications prescribed for older and younger patients in the registry, with biologics used more...
MADRID – Two studies show how obesity correlates with greater psoriatic arthritis disease activity and disability and how substantial weight loss...